As flagged by one of the profs, FDA has asked for some additional info and so the 5 August response date by FDA has been pushed out. Still expecting a decision from the FDA in this current September quarter.
Also cash balance is tight. If not for a bunch of options being exercised during the June quarter the company would have been up the creek. I guess they are waiting for FDA approval before raising some much needed capital. Baited breath stuff.
Ann: Quarterly Activities Report and Appendix 4C Cash Flow Report, page-3
Add EIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.035(14.6%) |
Mkt cap ! $167.7M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 30.0¢ | 27.5¢ | $9.305M | 32.49M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 75932 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 309841 | 8 |
View Market Depth
| Last trade - 12.53pm 09/10/2024 (20 minute delay) ? |
| EIQ (ASX) Chart |